+
Site Tour

PCRLV 2021: Tailoring mitral & tricuspid dedicated clip therapies by unlocking their full potential

Francesco Maisano and the expert panel focus on mitral and tricuspid dedicated clip therapies, including key learnings from case studies during a symposium held at PCR London Valves 2021.

Related Videos

PCRLV 2021: Transcatheter mitral valve replacement

Navitor™: Voice of the Experts Federico de Marco

M-TEER: echo procedural approach

AV VALVES 2023: TR – Atrial TR

AV VALVES 2023:Decision Making in HF–Tricuspid

TAVI Summit - Drive TAVI to the next level

T-TEER: Transcatheter Tricuspid Valve Repair - cases, tips, and tricks

EuroPCR 2023: Vascular access

LAAO Summit - Imaging debate: ICE

TRENDING TOPICS

EACTS 2024 - Novel approaches for Valvular and LVAD therapies

Reconsidering current approaches to valve and LVAD therapies

Early outcomes on Epic Max platform

Cleveland clinic (US) experience: Early outcomes and a perspective on porcine vs. bovine

Transfemoral TAVI

Navitor Vision 35 implantation

CONNEXT


HUB
RELATED RESOURCES

Epic Mitral – 10-Year Clinical Outcomes

ESC 2022: FMR

PCRLV 2021: Transcatheter mitral valve replacement

EuroEcho 2021: Tricuspid regurgitation: The Patient

CONNEXT


LIVE
RELATED EVENTS

LAAO Summit - Debate: Factor XI inhibitors

Now you've got Navitor.
Stable delivery.

AV Valves Summit 2024 | Closing of Day 2

Now you've got Navitor

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline